Healio (8/1, Miller) reports, “High remission rates were observed in patients with three or more follow-up visits after routine depression screening and treatment,” researchers concluded after utilizing “VitalSign6 – a software program that utilizes the PHQ-9 screening tool and supports treatment decisions – on a convenience sample of 25,000 patients (mean age, 40.88 years) who were previously screened with the PHQ-2.” The findings were published in the July/August issue of the Annals of Family Medicine. (SOURCE: APA Headlines)